Projected impact of travoprost versus both timolol and latanoprost on visual field deficit progression and costs among black glaucoma subjects.

Michael T. Halpern; Michael T. Halpern; D Covert; A Robin

Projected impact of travoprost versus both timolol and latanoprost on visual field deficit progression and costs among black glaucoma subjects.

Halpern, M., Covert, D., & Robin, A. (2002). Projected impact of travoprost versus both timolol and latanoprost on visual field deficit progression and costs among black glaucoma subjects. Transactions of the American Ophthalmological Society, 100, 109 - 118.

Copy citation